Computational Modeling and Simulation of the Bcl-2 Family: Paving the Way for Rational Drug Design

E-ISSN： 1875-533x|19|36|6081-6094

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.36, 2012-12, pp. : 6081-6094

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Rational Drug Design with the Aid of Molecular Modeling and Bioinformatics)

Current Pharmaceutical Design, Vol. 19, Iss. 12, 2013-04 ,pp. : 2245-2245

Bentham Science Publishers

Access to resources Recommend Favorite

Rational design of CCR2 antagonists: a survey of computational studies

By Sobhia Masilamani Elizabeth Singh Rajesh Kare Pavan Chavan Swapnil

Expert Opinion on Drug Discovery, Vol. 5, Iss. 6, 2010-06 ,pp. : 543-557

Informa Healthcare

Access to resources Recommend Favorite

The Bcl-2 Family as a Rational Target for the Treatment of B-Cell Chronic Lymphocytic Leukaemia

Current Medicinal Chemistry, Vol. 17, Iss. 9, 2010-03 ,pp. : 801-811

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery

Current Drug Targets, Vol. 19, Iss. 5, 2018-03 ,pp. : 501-526

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies in the Rational Drug Design

Current Medicinal Chemistry, Vol. 18, Iss. 17, 2011-06 ,pp. : 2517-2530

Bentham Science Publishers

Access to resources Recommend Favorite